ROCKWELL MEDICAL, INC. Cash and Cash Equivalents, Period Increase (Decrease)
ROCKWELL MEDICAL, INC. (RMTI) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$1.79 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-10
- ROCKWELL MEDICAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$1.79M.
- ROCKWELL MEDICAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $18.42M, a 307.65% increase year-over-year.
- ROCKWELL MEDICAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $2.54M.
- ROCKWELL MEDICAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$1.53M.
- ROCKWELL MEDICAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $14.31M.
- ROCKWELL MEDICAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$8.77M.
- ROCKWELL MEDICAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$14.02M.
- ROCKWELL MEDICAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$34.60M, a 164.17% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | -$1.79M 10-Q · filed 2019-05-10 | $16.63M derived: sum of 2 quarters · filed 2019-05-10 | $19.17M derived: sum of 3 quarters · filed 2019-05-10 | $17.64M derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2018-12-31 | $18.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $20.97M derived: sum of 2 quarters · filed 2019-03-18 | $19.44M derived: sum of 3 quarters · filed 2019-03-18 | $14.31M 10-K · filed 2019-03-18 | ||
| 2018-09-30 | $2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.01M derived: sum of 2 quarters · filed 2018-11-09 | -$4.11M 10-Q · filed 2018-11-09 | $404.40K derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2018-06-30 | -$1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$6.66M 10-Q · filed 2018-08-14 | -$2.14M derived: sum of 3 quarters · filed 2019-05-10 | -$6.72M derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2018-03-31 | -$5.13M 10-Q · filed 2019-05-10 | -$609.84K derived: sum of 2 quarters · filed 2019-05-10 | -$5.19M derived: sum of 3 quarters · filed 2019-05-10 | -$8.70M derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2017-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$57.14K derived: sum of 2 quarters · filed 2019-03-18 | -$3.57M derived: sum of 3 quarters · filed 2019-03-18 | -$8.77M 10-K · filed 2019-03-18 | ||
| 2017-09-30 | -$4.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$8.09M derived: sum of 2 quarters · filed 2018-11-09 | -$13.29M 10-Q · filed 2018-11-09 | -$15.41M derived: sum of 4 quarters · filed 2018-11-09 | ||
| 2017-06-30 | -$3.51M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-14 | -$8.72M 10-Q · filed 2018-08-14 | -$8.85M 10-Q · filed 2017-08-09 | -$10.83M derived: sum of 3 quarters · filed 2018-08-14 | -$15.36M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | -$5.21M 10-Q/A · filed 2018-08-14 | -$5.28M 10-Q · filed 2017-05-09 | -$7.32M derived: sum of 2 quarters · filed 2018-08-14 | -$11.85M derived: sum of 3 quarters · filed 2018-08-14 | -$18.03M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2016-12-31 | -$2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$6.64M derived: sum of 2 quarters · filed 2018-03-15 | -$12.83M derived: sum of 3 quarters · filed 2018-03-15 | -$14.02M 10-K · filed 2018-03-15 | ||
| 2016-09-30 | -$4.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$10.71M derived: sum of 2 quarters · filed 2017-11-08 | -$11.90M 10-Q · filed 2017-11-08 | -$13.88M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2016-06-30 | -$6.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$7.38M 10-Q · filed 2017-08-09 | -$9.35M derived: sum of 3 quarters · filed 2018-03-15 | -$13.32M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2016-03-31 | -$1.19M 10-Q · filed 2017-05-09 | -$3.17M derived: sum of 2 quarters · filed 2018-03-15 | -$7.14M derived: sum of 3 quarters · filed 2018-03-15 | -$33.33M derived: sum of 4 quarters · filed 2018-03-15 | ||
| 2015-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$5.95M derived: sum of 2 quarters · filed 2018-03-15 | -$32.13M derived: sum of 3 quarters · filed 2018-03-15 | -$34.60M 10-K · filed 2018-03-15 | ||
| 2015-09-30 | -$3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$30.16M derived: sum of 2 quarters · filed 2016-11-07 | -$32.63M 10-Q · filed 2016-11-07 | $30.16M derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2015-06-30 | -$26.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$28.65M 10-Q · filed 2016-08-09 | $34.13M derived: sum of 3 quarters · filed 2017-03-15 | $34.29M derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2015-03-31 | -$2.47M 10-Q · filed 2016-05-10 | $60.32M derived: sum of 2 quarters · filed 2017-03-15 | $60.47M derived: sum of 3 quarters · filed 2017-03-15 | $62.67M derived: sum of 4 quarters · filed 2017-03-15 | ||
| 2014-12-31 | $62.78M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $62.94M derived: sum of 2 quarters · filed 2017-03-15 | $65.14M derived: sum of 3 quarters · filed 2017-03-15 | $53.92M 10-K · filed 2017-03-15 | ||
| 2014-09-30 | $158.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $2.36M derived: sum of 2 quarters · filed 2015-11-09 | -$8.86M 10-Q · filed 2015-11-09 | -$18.20M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$9.02M 10-Q · filed 2015-08-04 | -$18.35M derived: sum of 3 quarters · filed 2016-02-29 | -$38.09M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | -$11.22M 10-Q · filed 2015-05-07 | -$20.55M derived: sum of 2 quarters · filed 2016-02-29 | -$40.29M derived: sum of 3 quarters · filed 2016-02-29 | -$5.11M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | -$9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$29.07M derived: sum of 2 quarters · filed 2016-02-29 | $6.11M derived: sum of 3 quarters · filed 2016-02-29 | $7.17M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | -$19.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $15.44M derived: sum of 2 quarters · filed 2014-11-10 | $16.50M 10-Q · filed 2014-11-10 | $20.04M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-06-30 | $35.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $36.24M 10-Q · filed 2014-07-31 | $39.78M derived: sum of 3 quarters · filed 2015-03-03 | $34.48M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-03-31 | $1.06M 10-Q · filed 2014-05-12 | $4.60M derived: sum of 2 quarters · filed 2015-03-03 | -$695.62K derived: sum of 3 quarters · filed 2015-03-03 | -$7.87M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2012-12-31 | $3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | -$1.76M derived: sum of 2 quarters · filed 2015-03-03 | -$8.93M derived: sum of 3 quarters · filed 2015-03-03 | -$1.00M 10-K · filed 2015-03-03 | ||
| 2012-09-30 | -$5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$12.47M derived: sum of 2 quarters · filed 2013-11-05 | -$4.54M 10-Q · filed 2013-11-05 | -$7.25M derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2012-06-30 | -$7.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $754.67K 10-Q · filed 2013-08-01 | -$1.95M derived: sum of 3 quarters · filed 2014-03-07 | -$2.85M derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2012-03-31 | $7.92M 10-Q · filed 2013-05-08 | $5.22M derived: sum of 2 quarters · filed 2014-03-07 | $4.32M derived: sum of 3 quarters · filed 2014-03-07 | $5.69M derived: sum of 4 quarters · filed 2014-03-07 | ||
| 2011-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$3.60M derived: sum of 2 quarters · filed 2014-03-07 | -$2.24M derived: sum of 3 quarters · filed 2014-03-07 | -$6.55M 10-K · filed 2014-03-07 | ||
| 2011-09-30 | -$896.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $469.51K derived: sum of 2 quarters · filed 2012-11-09 | -$3.84M 10-Q · filed 2012-11-09 | -$15.24M derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2011-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$2.95M 10-Q · filed 2012-08-07 | -$14.34M derived: sum of 3 quarters · filed 2013-03-18 | -$14.88M derived: sum of 4 quarters · filed 2013-03-18 | ||
| 2011-03-31 | -$4.31M 10-Q · filed 2012-05-07 | -$15.70M derived: sum of 2 quarters · filed 2013-03-18 | -$16.25M derived: sum of 3 quarters · filed 2013-03-18 | |||
| 2010-12-31 | -$11.39M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$11.94M derived: sum of 2 quarters · filed 2013-03-18 | -$10.77M 10-K · filed 2013-03-18 | |||
| 2010-09-30 | -$542.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $619.03K 10-Q · filed 2011-11-04 | ||||
| 2010-06-30 | $1.16M 10-Q · filed 2011-08-05 | |||||
| 2009-12-31 | $17.44M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |